ALK and neoplasm: Notably, the expression of HDAC1 and HDAC2 was comparable between ALK+ tumor cells and other immune cells, including T cells, B cells, and NK cells, suggesting that class I HDACs are abundant in normal and malignant immune-cell subsets.